Es Licenciada en Ciencias Biológicas de la Pontificia Universidad Católica de Chile y Doctora en Ciencias mención Microbiología de la Universidad de Chile. Realizó post-doctorados en la University of Pittsburgh y en Icahn School of Medicine, Nueva York (Estados Unidos). Se ha desempeñado como Profesor Asistente y Asociado en la Facultad de Ciencias Biológicas de la Universidad de Concepción, y actualmente es investigadora de la Facultad de Medicina y Ciencia de la Universidad San Sebastián, sede De La Patagonia. Trabaja en colaboración tanto con la academia como con hospitales públicos. Desde 2018 es la representante como Liaison Officer de Chile ante el International Centre for Genetic Engineering and Biotechnology siendo, además, seleccionada por el Programa Ciencia de Frontera 2019-2021 de la Academia Chilena de Ciencias.

In the Faculty of Medicine and Science he teaches the subjects General Microbiology and Microbiology I.

Our laboratory is interested in studying the immune response against infections produced by emerging viruses, the development of diagnostic tools, and the evaluation of vaccines with a translational medicine approach. Specifically, we are focused on: a) Studying the humoral and cellular immune response developed against SARS-CoV-2, and hantavirus in cohorts of patients in acute phase and convalescence. Knowing and understanding what type of immunity people exposed to these viruses develop and correlating this information with clinical characteristics will allow discovering biomarkers associated with COVID-19 and hantavirus disease, respectively. b) Development of human monoclonal antibodies against emerging viruses, such as hantavirus ANDV. This project aims to isolate and produce with recombinant DNA technology 100% human antibodies with the potential to be used as post-exposure therapy, and as prophylaxis and/or therapy in high-risk groups or in cases of hantavirus outbreaks.